Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?

Atkinson, Mark A; Powers, Alvin C

Atkinson, Mark A; Powers, Alvin C.

Atkinson MA; Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL 32601, USA; Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA; Diabetes Institute, University of Florida, Gainesville, FL, USA. Electronic address: atkinson@ufl.edu.
Powers AC; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA; VA Tennessee Valley Healthcare System, Nashville, TN, USA.

Lancet Diabetes Endocrinol ; 9(6): 328-329, 2021 06.

Article in English | MEDLINE | ID: covidwho-1246261

Subject(s)

COVID-19/blood; COVID-19/diagnosis; Diabetes Mellitus/blood; Diabetes Mellitus/diagnosis; Hyperglycemia/blood; Hyperglycemia/diagnosis; Animals; Blood Glucose/metabolism; COVID-19/complications; Diabetes Mellitus/etiology; Humans; Hyperglycemia/etiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus / COVID-19 / Hyperglycemia Type of study: Diagnostic study Topics: Long Covid Limits: Animals / Humans Language: English Journal: Lancet Diabetes Endocrinol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google